المؤلفون: M. Pippa, Palacios Fa, R. Aurichio, F. Hehn, L. Aliberti, Jussara A. L. Kochen, Gecilmara Salviato Pileggi, PG Lerner, M. Costa, T. A. C Silva, L. Rodrigues, M. Anauate, F. Omura, LB Fernandes, S. Lee, Imm Laurindo, CG Macedo, E. Azeka, E. Dourador, M. Baricelli, A. Hayata, J. Brudnewski, H. Mahlmann

المصدر: FRIDAY, 15 JUNE 2018.

مصطلحات موضوعية: myalgia, medicine.medical_specialty, education.field_of_study, business.industry, Population, medicine.disease, Vaccination, chemistry.chemical_compound, Tocilizumab, chemistry, Private practice, Internal medicine, medicine, Immune-mediated inflammatory diseases, medicine.symptom, Adverse effect, education, business, Meningitis

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::327e134913ba61ca8e6dd4930414860c
https://doi.org/10.1136/annrheumdis-2018-eular.4318